With the analysis among 1,838 patents, we discovered top 299 key players by total patent application. Novartis AG, F. Hoffmann-La Roche Ltd., Amgen Research (Munich) GmbH are dominant in this area. They take 18.55% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 154
F. Hoffmann-La Roche Ltd.
Amgen Research (Munich) GmbH
Hessen, Germany
Patent: 81
New Jersey, United States
Patent: 57
Washington, United States
Patent: 53
Bayern, Germany
Patent: 47
California, United States
Patent: 46
Cambridgeshire, United Kingdom
Patent: 42
California, United States
Patent: 38
With the analysis among 128 patents, we discovered top 12 start-ups by total patent application. Autolus Ltd., Hrain Biotechnology Co. Ltd., Systimmune, Inc. are active in this area.
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 22
Washington, United States
Patent: 20
Nanjing IASO Biotherapeutics Co., Ltd.
Jiangsu Sheng, China
Patent: 12
Juventas Cell Therapy Ltd.
Tianjin Shi, China
Patent: 12
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 9
Nanjing Bioheng Biotech Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Institut National de la Santé et de la Recherche Médicale
Aleta Biotherapeutics, Inc.
Massachusetts, United States
Patent: 2
With the analysis among related 1,094 patents applied in the last 5 years. We discover 278 most active companies in this area. The fast-growing Novartis AG, Kite Pharma, Inc., F. Hoffmann-La Roche Ltd. take 14.63% of patent filing during this period.
Basel-Stadt, Switzerland
Patent: 77
California, United States
Patent: 45
F. Hoffmann-La Roche Ltd.
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 29
Cambridgeshire, United Kingdom
Patent: 29
Bayern, Germany
Patent: 26
Lentigen Technology, Inc.
Washington, United States
Patent: 21
Massachusetts, United States
Patent: 21
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 20
With the analysis among related 1,094 patents in last 5 years, we discover 198 new entrants. Lentigen Technology, Inc., CRISPR Therapeutics AG, Millennium Pharmaceuticals, Inc. are the most active new entrants in this area.
Lentigen Technology, Inc.
Massachusetts, United States
Patent: 21
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 20
Washington, United States
Patent: 20
Indiana, United States
Patent: 17
Cellular Biomedicine Group, Inc.
California, United States
Patent: 16
Allogene Therapeutics, Inc.
California, United States
Patent: 16
Beijing Meikangji Free Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 14
California, United States
Patent: 12
With the analysis among 343 patents, we discovered top 44 universities and scientific research institutions by total patent application. Tsinghua University, University of Southern California, University of Minnesota are dominant in this area. They take 65.60% of the total patent filing.
Beijing Shi, China
Patent: 6
University of Southern California
California, United States
Patent: 5
Minnesota, United States
Patent: 5
Zhejiang Sheng, China
Patent: 5
Indian Institute of Technology Bombay
Maharashtra, India
Patent: 5
Julius-Maximilians-Universität Würzburg
The Scripps Research Institute
California, United States
Patent: 4
University of Connecticut Health Center
Connecticut, United States
Patent: 4
New York, United States
Patent: 3
National University of Singapore
Central Region, Singapore
Patent: 3